Introduction
Positron emission tomography/X-ray computed tomography (PET/CT) performed with 2-[ 
F-FDG) has become a useful and important oncologic technique [1, 2] . [ 18 F]-FDG PET/CT is recommended not only for preoperative staging and evaluation of recurrence [3] [4] [5] [6] but also for assessment of therapeutic responses [7, 8] . The maximum standardized uptake value (SUV max ), a simple and semiquantitative index of tumor metabolic activity, is widely used in oncologic [ Recent investigations have demonstrated that SUV max is a significant prognostic factor for overall survival and distant metastasis/recurrence-free survival [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] .
Moreover, two sets of criteria are available to quantify treatment responses in malignant tumors. The first set was developed by the European Organization for Research and Treatment of Cancer (EORTC) and published in 1999 by Young et al. [21] . The second is the PET Response Criteria in Solid Tumors (PERCIST), which was published in 2009 by Wahl et al. [22] . An evaluation of SUV is necessary for both criteria.
Malignant lesions often extend in all directions. Therefore, it is sometimes difficult for nuclear medicine physicians and radiologists to identify the location of maximum uptake within a lesion, and SUV max measurement therefore requires many time-consuming procedures and great effort.
Some manufacturers have developed semiautomatic SUV estimation tools. A typical tool creates a volume of interest (VOI) using a certain SUV threshold of uptake in the lesion and measures SUV max in VOI. However, these tools are ineffective for lesions with low SUV, because
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To address these problems, we devised a novel interface named SUV Navigator (SUVnavi). This interface was designed for accurate, rapid, and easy measurement of SUV max in a lesion.
We hypothesized that SUVnavi could accelerate the diagnostic process, and thus, the purpose of this study was to investigate the utility of SUVnavi for reducing the time required and for accurate measurement during image interpretation of SUV max on [
18 F]-FDG PET/CT. Furthermore, accuracy of SUV max measurements was evaluated.
Methods

Patients
From 2012 to 2014, 100 patients (mean age 64.6 ± 12.7 years, range 24-87; 60 men and 40 women) suspected of having malignant tumors were assessed; SUV max was measured in 661 lesions in those patients.
The protocol was approved by our institutional research ethics committee in accordance with the principles of the Declaration of Helsinki (approval No. 15160). Informed consent was not deemed necessary because this study was retrospective and noninvasive.
FDG PET scan
Each patient received an bolus of 185 MBq of [ 18 F]-FDG IV, and PET/CT images were acquired according to standard protocols using a PET/CT device (Discovery VCT, 64 multislice spiral CT; GE Healthcare, Milwaukee, WI, USA). Acquisition began 60 min after injection of [
18 F]-FDG. All patients fasted for 6 h before the injection. A nonenhanced, low-dose CT scan was acquired at 120 keV with auto-mA (20-100) for attenuation correction and anatomic localization, pitch 0.98:1, rotation speed 0.6 s, and table speed 39.37 mm/rotation. Data were reconstructed with a standard filter into transaxial slices with a field of view (FOV) 50 cm, matrix 512 × 512 (pixel size, 0.98 mm), and slice thickness 3.75 mm.
After the scan, PET images were obtained in three dimensions. Acquisition time per bed position was 3 min, and the scan had eight bed positions (head to mid thigh), with FOV 60 cm. Attenuation correction was based on the CT scan, and PET data were reconstructed into transaxial slices with a matrix size of 128 × 128 (pixel size 4.69 mm) and a slice thickness of 3.3 mm using iterative 3D ordered-subsets expectation maximization(OSEM) (two iterations, 14 subsets) with a 5.14-mm gaussian postprocessing filter. The resulting PET and CT images were coregistered on hardware (Advantage Workstation version 4.4; GE Healthcare).
SUVnavi
We used Visual Studio 2010 (Microsoft Corporation, Redmond, WA, USA) to develop PET/CT viewer software with SUVnavi. Our software reads Digital Imaging and Communications in Medicine (DICOM) files and displays transaxial, sagittal, coronal, PET, CT, and PET/CT fusion images on a personal computer with a Windows 7, 64-bit operating system (Microsoft). Data were transferred via ethernet connection without delay. A comparison of current versus previous study is able to load multiple studies simultaneously. SUVnavi presents SUV max information as bar graphs surrounding a cursor and as actual values on several upper and lower slices simultaneously without paging (Fig. 1 ). An operator can instantly identify the location of maximum uptake in the lesion, because this information is updated in real time. The algorithm is the following:
1. X and Y positions of the cursor are obtained on the current slice. 2. A circle is drawn by the software; the center of the circle is (X, Y), and the radius is designated by the user. 3. SUV max is searched for inside the circles. 4. SUV max is searched for inside the circles with designated radius on the current and several upper and lower slices; center positions of circles are (X, Y) on each slice; the number of slices is designated by the user. 5. SUV max is shown as graph bars on SUVnavi. 6. The slice with the highest SUV among obtained SUV max is assessed next. 7. An ROI is placed with visual confirmation by the user, adjacent high physiological uptake is not included. 8. SUV max in the lesion is obtained.
These procedures are performed immediately the cursor position is changed. Diagnoses and SUV max measurements were made in a randomized manner by two nuclear medicine physicians using three methods, as follows: (1) our viewer software with SUVnavi, (2) sliceby-slice 2D SUV measurement on the manufacturer's viewer software (2D measurement, AW 4·4, GE), and (3) volumetric 3D SUV measurement on the manufacturer's viewer software (3D measurement, AW 4·4, GE). Half the patients (N = 50) were evaluated first with SUVnavi and then 2D and 3D measurement and the remaining (N = 50) were evaluated first with 2D and 3D measurements and then with SUVnavi. After performing these evaluations, precise SUV max was measured with all three methods to assess the accuracies of measured SUV max . If the SUV max was the same in all methods, it was considered as being precise; otherwise, we repeated measurements in all methods until all results were equal and the result used as precise SUV max .
Statistics
A t test with Bonferroni correction was used to analyze differences in the time required to generate [ 18 F]-FDG PET/CT reports between 2D (Time_2D), 3D (Time_3D), and SUVnavi (Time_SUVnavi) measurements. Time saved using SUVnavi compared with 2D and 3D measurement (s-Time_2D and s-Time_3D, respectively) were calculated using the following formula: s-Time_2D = (Time_2D) − (Time_SUVnavi); s-Time_3D = (Time_3D) − (Time_SUVnavi). The relationship between s-Time and lesion number was assessed using Pearson's correlation coefficient. A t test was used to evaluate differences between SUV max attained with each method and precise SUV max . A P value <0.05 was considered significant. All statistical analyses were performed with GraphPad Prism ver.6 (GraphPad Software, Inc., CA, USA).
Results
The average number of lesions measured in each scan was 6.6; average Time_2D, Time_3D, and Time_SUVnavi were 11.1, 7.3, and 4.5 min, respectively; average time reduction with SUVnavi versus 2D was 53.8%, with a maximum reduction of 91.6%, and versus 3D was 37.5%, with a maximum reduction of 71.1%. The Time_SUVnavi was significantly shorter than the Time_2D and Time_3D (P < 0.001 and P < 0.001, respectively; Fig. 2) . The s-Time_2D and s-Time_3D ranged from 0.02 to 32.0 min (average 6.6 min) and from 0.2 to 10.7 min (average 2.8 min), respectively. The s-Times_2D and s-Times_3D had a positive correlation with lesion number (Fig. 3) . Two hundred and eighty-seven of the 661 lesions (43.4%) required adjustment of VOI size or threshold with 3D measurement.
Measured and precise SUV max agreed in only 466 of 661 lesions (70.5%), respectively, on 2D measurement and in all 661 lesions (100%) with 3D measurement and SUVnavi. In lesions with discrepant SUV max , those measured with 2D were overestimated in 15 of 661 (2.3%) Fig. 1 SUVnavi indicating maximum standard uptake value (SUV max ) in several upper and lower slices simultaneously without paging. The SUV max shown is the value from the lower slice (green bar) rather than the current slice and underestimated in 180 (27.2%). The average SUV max measured with 2D was significantly smaller than precise SUV max (Fig. 4) .
Discussion
In this study, we demonstrated that compared with 2D and 3D measurements, SUVnavi reduced the time to obtain SUV max measurement without reducing accuracy. The effect time reduction may have primarily originated from SUVnavi, because s-Time and lesion number had a positive correlation. Approximately 43% of lesions actually required adjustments of size or threshold with 3D measurements, and the procedures were time consuming. Perception of colors and shades by the human eye is limited; accordingly, detecting maximum uptake location is sometimes difficult. Therefore, the nuclear medicine physician and radiologist must frequently change the viewer window level and width and identify the slice and location of maximum lesion uptake to obtain precise SUV max . This procedure requires a huge amount of time and effort in 2D measurement. The procedure is simplified by using 3D measurement; however, SUV max location is occasionally placed in adjacent areas of very high physiological uptake, such as the bladder, in order to measure SUV of an intrapelvic tumor or metastatic lymph node with 3D. Consequently, frequent adjustment of VOI size or threshold may be required. SUVnavi can reduce both the required time and effort, because it shows the 3D SUV max at a glance, moves to the slice with the highest SUV among the obtained SUV max , and measures the lesion's SUV max . The ROI is placed with visual confirmation without including adjacent high physiological uptake. In fact, our results showed that the time required to perform SUV max measurement was reduced with SUVnavi. This effect was particularly remarkable for patients with many abnormal lesions.
SUVnavi may have several advantages over conventional interfaces. First, it may accelerate PET/CT image interpretation without reducing the accuracy of SUV max measurement. Expedited image interpretation reduces patient and clinician waiting times. Whereas some readers may think the power of SUVnavi is trivial, many nuclear medicine physicians and radiologists are required to generate a large number of reports, and we believe that SUVnavi will be a great advantage in busy institution. We managed approximately 1450 FDG-PET/CT scans per year before using SUVnavi and up to 1800 per year with SUVnavi. Second, SUVnavi will reduce fatigue because less time and effort is required to generate a PET/CT report.
SUVnavi is useful for identifying the region of maximum uptake. In this study, the interface was applied to evaluate SUV max , but in principle, SUVnavi can also be used to evaluate the SUV peak and may be useful for other indices, including tumor metabolic volume, because the SUV max in the lesion is required in order to evaluate these other indices.
Several limitations of this study should be noted. First, it was retrospective and limited to a single institution. In principle, SUVnavi is useful for rapid and easy measurement of SUV max in any circumstance because its advantage does not depend on a PET/CT scanner, tracer, patient profile, or condition; however, multicenter randomized trials are required to confirm its effects. Second, the order of software use may have affected the results but likely did not change results because, as mentioned above, half of the patients were first evaluated with SUVnavi and the remainder without.
Conclusion
In conclusion, SUVnavi may be useful for rapid and easy [ 18 F]-FDG PET/CT image interpretation without reducing the accuracy of SUV max measurement.
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